Tend to agree. It could very well be a loss leader. They will likely do this for drugs that serve a tiny patient population like this one. They get the goodwill

Tend to agree. It could very well be a loss leader. They will likely do this for drugs that serve a tiny patient population like this one. They get the goodwill of helping cancer patients save money as well.